Business · 18/06/2002
FDA to Host Public Meeting on Protection of Human Subjects in Clinical Trials
The US Food and Drug Administration (FDA) will host a public meeting to discuss the protection of human subjects in clinical trials, a key aspect of ensuring the safety and well-being of participants in medical research.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →